Li, L., Chen, R., Zhang, Y., Zhou, G., Chen, B., Zeng, Z., . . . Zhang, S. (2021). A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease. Frontiers in Immunology, 12, . https://doi.org/10.3389/fimmu.2021.646673
Chicago Style (17th ed.) CitationLi, Li, Rirong Chen, Yingfan Zhang, Gaoshi Zhou, Baili Chen, Zhirong Zeng, Minhu Chen, and Shenghong Zhang. "A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease." Frontiers in Immunology 12 (2021). https://doi.org/10.3389/fimmu.2021.646673.
MLA (8th ed.) CitationLi, Li, et al. "A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease." Frontiers in Immunology, vol. 12, 2021, https://doi.org/10.3389/fimmu.2021.646673.
Visit our Citation Styles guide for help on properly citing sources.